Advertisement

Fearful old world? A commentary on the Second International Summit on human genome editing

  • Andy GreenfieldEmail author
Article

Abstract

Genome editing is revolutionising our ability to modify genomes with exquisite precision for medical and agricultural applications, and in basic research. The first International Summit on Human Genome Editing, organised jointly by the US National Academies of Sciences and Medicine, the Chinese Academy of Sciences and the UK Royal Society, was held in Washington DC at the end of 2015. Its aim was to explore scientific, legal and ethical perspectives on the prospective use of human genome editing as a therapeutic intervention in disease (so-called somatic genome editing) and as a possible intervention in human reproduction (so-called germ-line genome editing). Following that Summit, the Organising Committee had, in a press release, come to the conclusion that: “It would be irresponsible to proceed with any clinical use of germ line editing unless and until (i) the relevant safety and efficacy issues have been resolved, based on appropriate understanding and balancing of risks, potential benefits and alternatives, and (ii) there is broad societal consensus about the appropriateness of the proposed application” (http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a). A report from the US National Academies subsequently reiterated and developed the approach.

Notes

Funding

This study was funded by Medical Research Council (UK) (Grant No. MC_U142684167).

References

  1. Adikusuma F, Piltz S, Corbett MA, Turvey M, McColl SR, Helbig KJ, Beard MR, Hughes J, Pomerantz RT, Thomas PQ (2018) Large deletions induced by Cas9 cleavage. Nature 560:E8–E9CrossRefGoogle Scholar
  2. Ayabe S, Nakashima K, Yoshiki A (2018) Off- and on-target effects of genome editing in mouse embryos. J Reprod Dev.  https://doi.org/10.1262/jrd.2018-128 CrossRefPubMedGoogle Scholar
  3. Codner GF, Mianne J, Caulder A, Loeffler J, Fell R, King R, Allan AJ, Mackenzie M, Pike FJ, McCabe CV, Christou S, Joynson S, Hutchison M, Stewart ME, Kumar S, Simon MM, Agius L, Anstee QM, Volynski KE, Kullmann DM, Wells S, Teboul L (2018) Application of long single-stranded DNA donors in genome editing: generation and validation of mouse mutants. BMC Biol 16:70CrossRefGoogle Scholar
  4. de Wert G, Pennings G, Clarke A, Eichenlaub-Ritter U, van El CG, Forzano F, Goddijn M, Heindryckx B, Howard HC, Radojkovic D, Rial-Sebbag E, Tarlatzis BC, Cornel MC, European Society of Human G, European Society of Human R, Embryology (2018) Human germline gene editing: Recommendations of ESHG and ESHRE. Eur J Hum Genet 26:445–449PubMedGoogle Scholar
  5. Egli D, Zuccaro MV, Kosicki M, Church GM, Bradley A, Jasin M (2018) Inter-homologue repair in fertilized human eggs? Nature 560:E5–E7CrossRefGoogle Scholar
  6. Fogarty NME, McCarthy A, Snijders KE, Powell BE, Kubikova N, Blakeley P, Lea R, Elder K, Wamaitha SE, Kim D, Maciulyte V, Kleinjung J, Kim JS, Wells D, Vallier L, Bertero A, Turner JMA, Niakan KK (2017) Genome editing reveals a role for OCT4 in human embryogenesis. Nature 550:67–73CrossRefGoogle Scholar
  7. Greenfield A (2018a) I remember where I was when I heard about the world’s first genome-edited babies. Bionews 978. https://www.bionews.org.uk/page_140216
  8. Greenfield A (2018b) Carry on Editing. Br Med Bull 127:23–31CrossRefGoogle Scholar
  9. Greenfield A, Braude P, Flinter F, Lovell-Badge R, Ogilvie C, Perry ACF (2017) Assisted reproductive technologies to prevent human mitochondrial disease transmission. Nat Biotechnol 35:1059–1068CrossRefGoogle Scholar
  10. Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR (2018) Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556:57–63CrossRefGoogle Scholar
  11. Jasanoff S, Hurlbut JB (2018) A global observatory for gene editing. Nature 555:435–437CrossRefGoogle Scholar
  12. Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR (2017) Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions. Nat Biotechnol 35:371–376CrossRefGoogle Scholar
  13. Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420–424CrossRefGoogle Scholar
  14. Kosicki M, Tomberg K, Bradley A (2018) Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol 36:765–771CrossRefGoogle Scholar
  15. Liang P, Ding C, Sun H, Xie X, Xu Y, Zhang X, Sun Y, Xiong Y, Ma W, Liu Y, Wang Y, Fang J, Liu D, Songyang Z, Zhou C, Huang J (2017) Correction of beta-thalassemia mutant by base editor in human embryos. Protein Cell 8:811–822CrossRefGoogle Scholar
  16. Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K, Koski A, Ji D, Hayama T, Ahmed R, Darby H, Van Dyken C, Li Y, Kang E, Park AR, Kim D, Kim ST, Gong J, Gu Y, Xu X, Battaglia D, Krieg SA, Lee DM, Wu DH, Wolf DP, Heitner SB, Belmonte JCI, Amato P, Kim JS, Kaul S, Mitalipov S (2017) Correction of a pathogenic gene mutation in human embryos. Nature 548:413–419CrossRefGoogle Scholar
  17. Ma H, Marti-Gutierrez N, Park SW, Wu J, Hayama T, Darby H, Van Dyken C, Li Y, Koski A, Liang D, Suzuki K, Gu Y, Gong J, Xu X, Ahmed R, Lee Y, Kang E, Ji D, Park AR, Kim D, Kim ST, Heitner SB, Battaglia D, Krieg SA, Lee DM, Wu DH, Wolf DP, Amato P, Kaul S, Belmonte JCI, Kim JS, Mitalipov S (2018) Ma et al. reply. Nature 560:E10–E23CrossRefGoogle Scholar
  18. National Academies of Sciences, Engineering and Medicine (2017) Human genome editing: science, ethics and governance. National Academies Press, Washington DCGoogle Scholar
  19. Nuffield Council on Bioethics (2018) Genome Editing and human reproduction: social and ethcial issues. Nuffield Council on Bioethics, LondonGoogle Scholar
  20. Rees HA, Komor AC, Yeh WH, Caetano-Lopes J, Warman M, Edge ASB, Liu DR (2017) Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery. Nat Commun 8:15790CrossRefGoogle Scholar
  21. Shin HY, Wang C, Lee HK, Yoo KH, Zeng X, Kuhns T, Yang CM, Mohr T, Liu C, Hennighausen L (2017) CRISPR/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat Commun 8:15464CrossRefGoogle Scholar
  22. Steffann J, Jouannet P, Bonnefont JP, Chneiweiss H, Frydman N (2018) Could failure in preimplantation genetic diagnosis justify editing the human embryo genome? Cell Stem Cell 22:481–482CrossRefGoogle Scholar
  23. Yang H, Li Y, Zuo E, Sun Y, Wei W, Yuan T, Ying W, Steinmetz L (2018) Base editing generates substantial off-target single nucleotide variants. Biorxiv.  https://doi.org/10.1101/480145 CrossRefGoogle Scholar
  24. Yeh WH, Chiang H, Rees HA, Edge ASB, Liu DR (2018) In vivo base editing of post-mitotic sensory cells. Nat Commun 9:2184CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.MRC Mammalian Genetics UnitHarwell InstituteHarwellUK

Personalised recommendations